Journal of Organometallic Chemistry p. 129 - 137 (1997)
Update date:2022-08-04
Topics:
Walther, Dirk
Klettke, Thomas
Goerls, Helmar
Imhof, Wolfgang
(cod)2Ni reacts with Ph3Si-C≡C-CMe3 to form the mixed complex (cod)Ni(alkyne) (1), (cdt)Ni and Ph3Si-C≡C-CMe3 yield the homoleptic compound (alkyne)2Ni (2) (cod: cyclooca-1.5-diene, cdt: cyclododeca-1.5.9-triene). Both crystal structures were determined by X-ray diffraction analysis. In 2 the Ni(0) center is surrounded by the four carbon atoms of the alkynes yielding a distorted nickel-centered C4 tetrahedron (NiC4). Reaction of the alkynylsilanes Ph2Si(-C≡C-R)2 (R = CMe3, SiMe3) and of PhSi(-≡C-CMe3)2 with (cdt)Ni gives dimeric compounds of the type [(alkinylsilane)Ni(0)]2 (3-5), which have been characterized by X-ray diffraction determination. 3-5 show very similar structures in the solid state. Two silicon-centered C4 tetrahedra (SiC4) are connected with two NiC4 tetrahedra by the four carbon atoms which are related to the two different kinds of tetrahedra. This structural principle can be compared with the structure of tetrasiloxanes. According to the temperature-dependent 13C NMR spectra of 5 several conformers can be detected in solution.
Xi'an yuanfar international trade company
website:https://www.yuanfarchemical.com
Contact:86-029-88745613 ext 828
Address:Floor19th ,B Building, Oak Block,No.36 South Fenghui Road, Dev. Zone of High-Tech Ind.,Xi’an, China
Suzhou Kangrun Pharmaceutical, Inc
Contact:86-512-63912376，63913329
Address:Building 2, No. 2358 ,Chang'an Rd, Wujiang Economic Development Zone Pioneering park, china
Guangzhou Reachin Chemical Co., Ltd
Contact:+86-20-37087379 ext.604
Address:A122C-1, Tianyuan Plaza, 401 Tianyuan Rd., Tianhe, Guangzhou, China
Chuzhou Baiao Biologhy S&T Co., Ltd.
Contact:+86-25-83212599；+86-25-83212699 13705185959
Address:Room 905, Tianzheng International Platza, No.399, Zhongyang Road ,Nanjing, Jiangsu Province, China
qingdao goldenchem imp and exp co.,ltd.
Contact:532-55579246
Address:no.62 ,haier road laoshan distirct
Doi:10.1016/j.tet.2009.07.032
(2009)Doi:10.1016/S0008-6215(98)00214-6
(1998)Doi:10.1002/cber.19691020343
(1969)Doi:10.1016/S0040-4020(01)82796-4
(1969)Doi:10.1021/acsmedchemlett.9b00219
(2019)Doi:10.1039/C29690000877
(1969)
